COMPOSITION FOR PREVENTING OR TREATING BENIGN PROSTATIC HYPERPLASIA CONTAINING CINCHONINE AS ACTIVE COMPONENT

摘要

The present invention relates to a composition for preventing or treating benign prostatic hyperplasia, which contains cinchonine as an active component. When cinchonine of the present invention is treated to human benign prostate hyperplasia organoid, it is possible to effectively suppress organoid formation with a significantly lower concentration compared to a treatment concentration of an existing benign prostatic hyperplasia drug to have an excellent effect of preventing and treating benign prostatic hyperplasia. Thus, the cinchonine can be usefully used in related industries.;COPYRIGHT KIPO 2020